Evoke Pharma, Inc. (EVOK)

Evoke Pharma Revenue

Evoke Pharma had revenue of $3.75M in the quarter ending June 30, 2025, with 47.06% growth. This brings the company's revenue in the last twelve months to $12.79M, up 70.02% year-over-year. In the year 2024, Evoke Pharma had annual revenue of $10.25M with 97.84% growth.

• Revenue (ttm): $12.79M
• Revenue Growth: +70.02%
• P/S Ratio: 1.05
• Revenue / Employee: $4,264,953
• Employees: 3
• Market Cap: 10.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.25M	5.07M	97.84%
Dec 31, 2023	5.18M	2.67M	106.51%
Dec 31, 2022	2.51M	890.57K	55.04%
Dec 31, 2021	1.62M	1.60M	6,929.00%
Dec 31, 2020	23.02K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.